Cargando…

Brd2/4 and Myc regulate alternative cell lineage programmes during early osteoclast differentiation in vitro

Osteoclast (OC) development in response to nuclear factor kappa-Β ligand (RANKL) is critical for bone homeostasis in health and in disease. The early and direct chromatin regulatory changes imparted by the BET chromatin readers Brd2-4 and OC-affiliated transcription factors (TFs) during osteoclastog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caputo, Valentina S., Trasanidis, Nikolaos, Xiao, Xiaolin, Robinson, Mark E., Katsarou, Alexia, Ponnusamy, Kanagaraju, Prinjha, Rab K., Smithers, Nicholas, Chaidos, Aristeidis, Auner, Holger W., Karadimitris, Anastasios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807155/ https://www.ncbi.nlm.nih.gov/pubmed/33490899 http://dx.doi.org/10.1016/j.isci.2020.101989

Ejemplares similares

The innate sensor ZBP1-IRF3 axis regulates cell proliferation in multiple myeloma
por: Ponnusamy, Kanagaraju, et al.
Publicado: (2021)

Chromatin-based, in cis and in trans regulatory rewiring underpins distinct oncogenic transcriptomes in multiple myeloma
por: Alvarez-Benayas, Jaime, et al.
Publicado: (2021)

MAF functions as a pioneer transcription factor that initiates and sustains myelomagenesis
por: Katsarou, Alexia, et al.
Publicado: (2023)

CAR-iNKT cells targeting clonal TCRVβ chains as a precise strategy to treat T cell lymphoma
por: Rowan, Aileen G., et al.
Publicado: (2023)

Combined Inhibition of p97 and the Proteasome Causes Lethal Disruption of the Secretory Apparatus in Multiple Myeloma Cells
por: Auner, Holger W., et al.
Publicado: (2013)

Repeatability and test–retest reproducibility of mean apparent diffusion coefficient measurements of focal and diffuse disease in relapsed multiple myeloma at 3T whole body diffusion-weighted MRI (WB-DW-MRI)
por: ElGendy, Khalil, et al.
Publicado: (2022)

Bortezomib Amplifies Effect on Intracellular Proteasomes by Changing Proteasome Structure()
por: Pitcher, David S., et al.
Publicado: (2015)

MYC protein stability is negatively regulated by BRD4
por: Devaiah, Ballachanda N., et al.
Publicado: (2020)

BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells
por: Coudé, Marie-Magdelaine, et al.
Publicado: (2015)

High resolution IgH repertoire analysis reveals fetal liver as the likely origin of life-long, innate B lymphopoiesis in humans
por: Roy, Anindita, et al.
Publicado: (2017)

Transcriptional regulation of BRD7 expression by Sp1 and c-Myc
por: Liu, Huaying, et al.
Publicado: (2008)

Brd4‐Brd2 isoform switching coordinates pluripotent exit and Smad2‐dependent lineage specification
por: Fernandez‐Alonso, Rosalia, et al.
Publicado: (2017)

BRD4 Short Isoform Interacts with RRP1B, SIPA1 and Components of the LINC Complex at the Inner Face of the Nuclear Membrane
por: Alsarraj, Jude, et al.
Publicado: (2013)

Systems level profiling of chemotherapy-induced stress resolution in cancer cells reveals druggable trade-offs
por: Saavedra-García, Paula, et al.
Publicado: (2021)

N-terminal BET bromodomain inhibitors disrupt a BRD4-p65 interaction and reduce inducible nitric oxide synthase transcription in pancreatic β-cells
por: Nord, Joshua A., et al.
Publicado: (2022)

Chromatin targeting drugs in cancer and immunity
por: Prinjha, Rab, et al.
Publicado: (2013)

Muscle hypertrophy in hypoxia with inflammation is controlled by bromodomain and extra-terminal domain proteins
por: Chabert, Clovis, et al.
Publicado: (2017)

Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression
por: Li, Gong-Quan, et al.
Publicado: (2015)

Targeted Overexpression of Osteoactivin in Cells of Osteoclastic Lineage Promotes Osteoclastic Resorption and Bone Loss in Mice
por: Sheng, Matilda H.-C., et al.
Publicado: (2012)

I-BET151 suppresses osteoclast formation and inflammatory cytokines secretion by targetting BRD4 in multiple myeloma
por: Guo, Ning-Hong, et al.
Publicado: (2019)

Bromodomain inhibitor I‐BET151 suppresses immune responses during fungal–immune interaction
por: Domínguez‐Andrés, Jorge, et al.
Publicado: (2019)

Drawing on disorder: How viruses use histone mimicry to their advantage
por: Tarakhovsky, Alexander, et al.
Publicado: (2018)

Targeting bromodomain-containing protein 4 (BRD4) inhibits MYC expression in colorectal cancer cells
por: Otto, C., et al.
Publicado: (2019)

Berbamine Suppresses the Growth of Gastric Cancer Cells by Inactivating the BRD4/c-MYC Signaling Pathway
por: Li, Hongchun, et al.
Publicado: (2022)

BRD7 Promotes Cell Proliferation and Tumor Growth Through Stabilization of c-Myc in Colorectal Cancer
por: Zhao, Ran, et al.
Publicado: (2021)

Nucleophosmin 1 cooperates with BRD4 to facilitate c-Myc transcription to promote prostate cancer progression
por: Hong, Zhe, et al.
Publicado: (2023)

G6PD deficiency in patients identified as female
por: Bain, Barbara J., et al.
Publicado: (2022)

BRD4 methylation by the methyltransferase SETD6 regulates selective transcription to control mRNA translation
por: Vershinin, Zlata, et al.
Publicado: (2021)

Inhibition of BET Proteins Reduces Right Ventricle Hypertrophy and Pulmonary Hypertension Resulting from Combined Hypoxia and Pulmonary Inflammation
por: Chabert, Clovis, et al.
Publicado: (2018)

Compensatory induction of MYC expression by sustained CDK9 inhibition via a BRD4-dependent mechanism
por: Lu, Huasong, et al.
Publicado: (2015)

BRD4-targeted therapy induces Myc-independent cytotoxicity in Gnaq/11-mutatant uveal melanoma cells
por: Ambrosini, Grazia, et al.
Publicado: (2015)

PIK3CA Cooperates with KRAS to Promote MYC Activity and Tumorigenesis via the Bromodomain Protein BRD9
por: Bell, Catherine M., et al.
Publicado: (2019)

The BRD4 inhibitor JQ1 suppresses tumor growth by reducing c-Myc expression in endometrial cancer
por: Pang, Yingxin, et al.
Publicado: (2022)

BRD4 localization to lineage-specific enhancers is associated with a distinct transcription factor repertoire
por: Najafova, Zeynab, et al.
Publicado: (2017)

Knee loading inhibits osteoclast lineage in a mouse model of osteoarthritis
por: Li, Xinle, et al.
Publicado: (2016)

Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma
por: Venkataraman, Sujatha, et al.
Publicado: (2014)

Correction: Compensatory induction of MYC expression by sustained CDK9 inhibition via a BRD4-dependent mechanism
por: Lu, Huasong, et al.
Publicado: (2015)

BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph(+) chronic myeloid leukemia
por: Peter, Barbara, et al.
Publicado: (2022)

An inhibitor of BRD4, GNE987, inhibits the growth of glioblastoma cells by targeting C-Myc and S100A16
por: Ma, Liya, et al.
Publicado: (2022)

Bromodomain Inhibitors Modulate FcγR-Mediated Mononuclear Phagocyte Activation and Chemotaxis
por: Banham, Gemma D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l3c23q8vc6p5emkni617vvvv56